3. Ms R complains the Trust did not take account of her family history in a risk assessment in April 2018. She complains the Trust did not offer her the breast cancer gene (BRCA) mutation test (a blood or saliva test to look for changes in DNA that increase the risk of breast cancer) and refused to address all the concerns she raised in her complaint.
4. Ms R says the Trust failed to take account of genetic factors (her family history) in her score. Ms R was diagnosed with triple-negative breast cancer (TNBC) (a breast cancer that lacks or shows low levels of two female hormones and a protein) in May 2020, which is a direct result of being a carrier of the BRCA1 gene mutation. The BRCA gene is a gene that produces proteins that help repair damaged DNA. A BRCA gene mutation is when the DNA that makes up the gene becomes damaged. As a result, the BRCA is no longer effective at repairing broken DNA and helping prevent breast cancer.
5. Ms R wants service improvements and for the Trust to accept its failure and apologise to her.
6. Ms R wants financial compensation for the risk of the cancer returning, an increased risk of other cancers, a risk to her fertility and of developing lymphedema (a long-term condition that causes swelling in the body’s tissues), and the delay in being able to start a family. She also says the events have caused potential damage to her career prospects because of having to take extended sick leave.
7. Ms R also wants financial compensation for the discomfort caused by chemotherapy treatments (in which medicine is used to kill cancer cells) and the effects of Zoladex (a medication used to suppress production of the sex hormones, particularly in the treatment of breast and prostate cancer), vein damage and painful scarring from the sentinel lymph node biopsy (a test to find the first lymph node or nodes a cancer may spread to). She also wants financial compensation for the stress, anxiety and negative effects on her mental health for which she has had to ask for financial support.